Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Ophthalmology. 2014 Apr 24;121(8):1547–1557.e1. doi: 10.1016/j.ophtha.2014.01.036

Table 5.

Complications by Neovascular Glaucoma (NVG) versus other strata (1, 2, 4).

Complication Year 3 N, Cumulative proportion
(Standard Error)(SE)
log-rank
p-value
NVG Other Diagnosis
Tube occlusion 3 5.5% (3.2%) 4, 2.3% (1.1%) 0.31
Choroidal effusion 1 1.8% (1.7%) 1, 0.6% (0.6%) 0.42
Suprachoroidal hemorrhage 0 0.0% NA 0 0.0% NA NA
Endophthalmitis 0 0.0% NA 1 0.5% (0.5%) 0.54
Cystoid Macular Edema 1 1.9% (1.9%) 9 5.2% (1.7%) 0.29
Shallow Anterior Chamber 2 6.1% (4.2%) 2 1.5% (1.0%) 0.13
Hypotony maculopathy 1 0.5% (0.5%) 0 0.0% NA 0.54
Diplopia 4 6.1% (3.0%) 26 14.4% (2.6%) 0.085
Corneal edema, All 2 5.1% (3.6%) 27 17.8% (3.1%) 0.039
Tube-corneal touch 3 5.4% (3.0%) 5 3.0% (1.3%) 0.42
Corneal graft rejection 0 0.0% NA 9 5.4% (1.8%) 0.079
Band Keratopathy 1 1.4% (1.4%) 0 0.0% NA 0.10
Corneal neovascularization 0 0.0% NA 1 0.7% (0.7%) 0.59
Anterior Synechiae 0 0.0% NA 1 0.7% (0.7%) 0.59
Tube erosion 1 2.0% (1.9%) 2 1.2% (0.8%) 0.74
Encysted Bleb 0 0.0% NA 1 0.6% (0.6%) 0.56
Recurrent or persistent iritis 2 3.5% (2.4%) 9 5.2% (1.7%) 0.55
Phthisis bulbi 4 7.8% (3.8%) 1 0.5% (0.5%) 0.004
Hyphema 4 5.9% (2.9%) 0 0.0% NA 0.001
Vitreous hemorrhage 6 10.2% (4.0%) 0 0.0% NA <0.001
Pupillary membrane 1 1.6% (1.6%) 0 0.0% NA 0.089
Epiretinal membrane 1 1.4% (1.4%) 0 0.0% NA 0.10
Retinal Detachment 4 6.4% (3.1%) 0 0.0% NA 0.001
Corneal blood staining 2 2.8% (2.0%) 0 0.0% NA 0.020
Total Patients with Late Complications 34 53.0% (6.5%) 84 46.4% (3.8%) 0.57

In the one year follow-up report, the complications of 4 eyes occurring after complications explant of the study device were included in percentages

*

Risk greater than 1.0 is associated with higher risk in NVG eyes, a risk less than 1.0 is associated with a higher risk in eyes with other diagnoses.

**

Cox proportional hazards model did not converge

After publication of the one year report, the Data and Safety Monitoring Committee decided that one case of endophthalmitis was due to a corneal transplant which occurred after implantation of the study shunt and that the necessity of performing the corneal transplant was due to pre-existing corneal disease and not the study shunt